SingleCell Biotechnology

About

SingleCell Biotechnology has developed a new platform of assays to target highly aggressive and invasive cancers. The platform consists of three phenotype assays that recapitulate dormancy, migration, and single cell clonogenicity of tumor stem cells. These stem cells make up the hallmark characteristics of aggressive and highly invasive cancers responsible for recurrence and mortality. Each assay is designed to collect high content and high throughput data necessary for drug discovery and disease analysis. The platform can be used for screening drug libraries and identifying druggable targets for killing or disrupting dormant and migrating cells to expedite and de-risk the drug development process.